Welcome to our dedicated page for Vigil Neuroscience SEC filings (Ticker: VIGL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vigil Neuroscience filings document the company’s public-company status, capital structure, governance and biotechnology disclosure record. Recent corporate-status filings include a Form 25 covering removal of its common stock from Nasdaq listing and registration under Section 12(b), and a Form 15 covering termination of Section 12(g) registration or suspension of Exchange Act reporting duties, with one holder of record identified in the certification.
The company’s 8-K disclosures cover material events, material agreements, shareholder voting matters, capital-structure items, governance matters, clinical or regulatory disclosures, and operating and financial results tied to its microglia-focused neurodegenerative disease programs.